“Bio Studies of Novel Macrocyclic Sulfazan and Linear Sulfazan (Creation, Analysis and Anticancer Assessment)”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 351–363, Oct. 2022, doi: 10.47750/pnr.2022.13.04.043.